These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

515 related items for PubMed ID: 32392266

  • 1. Abrogation of pathogenic attributes in drug resistant Candida auris strains by farnesol.
    Srivastava V, Ahmad A.
    PLoS One; 2020; 15(5):e0233102. PubMed ID: 32392266
    [Abstract] [Full Text] [Related]

  • 2. Transcriptional Profiling of the Candida auris Response to Exogenous Farnesol Exposure.
    Jakab Á, Balla N, Ragyák Á, Nagy F, Kovács F, Sajtos Z, Tóth Z, Borman AM, Pócsi I, Baranyai E, Majoros L, Kovács R.
    mSphere; 2021 Oct 27; 6(5):e0071021. PubMed ID: 34643421
    [Abstract] [Full Text] [Related]

  • 3. Comparative transcriptional analysis of Candida auris biofilms following farnesol and tyrosol treatment.
    Jakab Á, Kovács F, Balla N, Nagy-Köteles C, Ragyák Á, Nagy F, Borman AM, Majoros L, Kovács R.
    Microbiol Spectr; 2024 Apr 02; 12(4):e0227823. PubMed ID: 38440972
    [Abstract] [Full Text] [Related]

  • 4. The quorum-sensing molecule farnesol is a modulator of drug efflux mediated by ABC multidrug transporters and synergizes with drugs in Candida albicans.
    Sharma M, Prasad R.
    Antimicrob Agents Chemother; 2011 Oct 02; 55(10):4834-43. PubMed ID: 21768514
    [Abstract] [Full Text] [Related]

  • 5. Transcriptome Assembly and Profiling of Candida auris Reveals Novel Insights into Biofilm-Mediated Resistance.
    Kean R, Delaney C, Sherry L, Borman A, Johnson EM, Richardson MD, Rautemaa-Richardson R, Williams C, Ramage G.
    mSphere; 2018 Jul 11; 3(4):. PubMed ID: 29997121
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of farnesol on Candida dubliniensis biofilm formation and fluconazole resistance.
    Jabra-Rizk MA, Shirtliff M, James C, Meiller T.
    FEMS Yeast Res; 2006 Nov 11; 6(7):1063-73. PubMed ID: 17042756
    [Abstract] [Full Text] [Related]

  • 9. Activities of nine antifungal agents against Candida auris biofilms.
    Chatzimoschou A, Giampani A, Meis JF, Roilides E.
    Mycoses; 2021 Apr 11; 64(4):381-384. PubMed ID: 33270284
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Candida auris: a comparison between planktonic and biofilm susceptibility to antifungal drugs.
    Romera D, Aguilera-Correa JJ, Gadea I, Viñuela-Sandoval L, García-Rodríguez J, Esteban J.
    J Med Microbiol; 2019 Sep 11; 68(9):1353-1358. PubMed ID: 31271350
    [Abstract] [Full Text] [Related]

  • 12. In vitro inhibitory effects of farnesol and interactions between farnesol and antifungals against biofilms of Candida albicans resistant strains.
    Xia J, Qian F, Xu W, Zhang Z, Wei X.
    Biofouling; 2017 Apr 11; 33(4):283-293. PubMed ID: 28317391
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model.
    Bozó A, Domán M, Majoros L, Kardos G, Varga I, Kovács R.
    J Microbiol; 2016 Nov 11; 54(11):753-760. PubMed ID: 27796932
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Screening of the global health priority BoxⓇ reveals potential new disinfectants against the emerging multidrug-resistant pathogen Candida auris.
    Retore YI, Lucini F, Pimentel LR, de Oliveira HC, Simionatto S, Rossato L.
    Microb Pathog; 2024 Sep 11; 194():106828. PubMed ID: 39079575
    [Abstract] [Full Text] [Related]

  • 20. Mutations in TAC1B: a Novel Genetic Determinant of Clinical Fluconazole Resistance in Candida auris.
    Rybak JM, Muñoz JF, Barker KS, Parker JE, Esquivel BD, Berkow EL, Lockhart SR, Gade L, Palmer GE, White TC, Kelly SL, Cuomo CA, Rogers PD.
    mBio; 2020 May 12; 11(3):. PubMed ID: 32398311
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.